300244 Stock Overview
Operates as a third-party independent medical diagnostic service company in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Dian Diagnostics Group Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.99 |
| 52 Week High | CN¥27.98 |
| 52 Week Low | CN¥13.73 |
| Beta | 0.48 |
| 1 Month Change | -6.67% |
| 3 Month Change | -29.34% |
| 1 Year Change | -46.32% |
| 3 Year Change | -63.67% |
| 5 Year Change | -25.43% |
| Change since IPO | -61.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300244 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -6.4% | -1.2% | -0.5% |
| 1Y | -46.3% | -30.1% | -11.3% |
Return vs Industry: 300244 underperformed the CN Healthcare industry which returned -29.7% over the past year.
Return vs Market: 300244 underperformed the CN Market which returned -10.4% over the past year.
Price Volatility
| 300244 volatility | |
|---|---|
| 300244 Average Weekly Movement | 5.6% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in CN Market | 10.8% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300244's share price has been volatile over the past 3 months.
Volatility Over Time: 300244's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 10,843 | Haibin Chen | www.dazd.cn |
Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions.
Dian Diagnostics Group Co.,Ltd. Fundamentals Summary
| 300244 fundamental statistics | |
|---|---|
| Market cap | CN¥8.67b |
| Earnings (TTM) | CN¥170.36m |
| Revenue (TTM) | CN¥13.15b |
50.9x
P/E Ratio0.7x
P/S RatioIs 300244 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300244 income statement (TTM) | |
|---|---|
| Revenue | CN¥13.15b |
| Cost of Revenue | CN¥9.32b |
| Gross Profit | CN¥3.83b |
| Other Expenses | CN¥3.66b |
| Earnings | CN¥170.36m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.28 |
| Gross Margin | 29.11% |
| Net Profit Margin | 1.30% |
| Debt/Equity Ratio | 41.1% |
How did 300244 perform over the long term?
See historical performance and comparison